Fig. 3From: Meta-analysis examining overall survival in patients with pancreatic cancer treated with second-line 5-fluorouracil and oxaliplatin-based therapy after failing first-line gemcitabine-containing therapy: effect of performance status and comparison with other regimensOverall survival (OS) meta-analysis of 5-fluorouracil (5-FU) and oxaliplatin (OXA)-based therapyBack to article page